PfizervsThermo Fisher Scientific

PFE and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Pfizer (PFE) has a market value of $164B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, PFE moved +19.2% and TMO +19.5%. The P/E is 40.7 for PFE and 36.8 for TMO. Dividend yield: PFE 5.95%, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PFE$164B

    TMO$260B

    TMO is 1.6 times PFE

  • Revenue, 12 months

    PFE$63.6B

    TMO$47.4B

    PFE is 1.3 times TMO

  • Net income, 12 months

    PFE$4.0B

    TMO$7.1B

    TMO is 1.8 times PFE

  • Operating margin

    PFE–

    TMO17.9%

  • ROIC

    PFE2.2%

    TMO8.2%

    6.0 points apart

  • P/E

    PFE40.7

    TMO36.8

    PFE is 1.1 times TMO

  • Dividend yield

    PFE5.9%

    TMO0.3%

    5.7 points apart

  • 5-year return

    PFE-23.8%

    TMO+11.8%

    35.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PFE-23.8%

TMO+11.8%

507510012520222023202420252026
Returns by period
PeriodPFEWith dividendsTMOWith dividends
1 year since November 12, 2025+19.2%Price +11.7%+19.5%Price +19.1%
3 years since November 13, 2023+21.1%+6.6% a yearPrice -0.3%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021-23.8%-5.3% a yearPrice -41.9%+11.8%+2.3% a yearPrice +10.2%
10 years since November 15, 2016+49.7%+4.1% a yearPrice -5.5%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PFEPfizerTMOThermo Fisher Scientific

Valuation

PFETMO
Valuation
Price$28.89$700.22
Market value$164B$260B
Enterprise value (EV)$216B$295B
P/E40.736.8
P/E, 5-year median18.332.7
P/B1.94.8
EV/EBIT50.734.9
Free cash flow yield7.2%2.9%

Results and growth

PFETMO
Results and growth
Revenue, 12 months$63.6B$47.4B
Net income, 12 months$4.0B$7.1B
Free cash flow, 12 months$11.8B$7.6B
Earnings per share, 12 months$0.70$18.96
Revenue growth, year on year-1.7%3.9%
Revenue growth a year, past+8.5%over 5 years+6.7%over 5 years
EPS growth a year, past-3.6%over 5 years+2.1%over 5 years

Margins and returns on capital

PFETMO
Margins and returns on capital
Gross margin73.4%–
Operating margin–17.9%
Net margin6.3%14.9%
ROIC2.2%8.2%
ROE4.6%13.4%

Balance sheet

PFETMO
Balance sheet
Cash$10.9B$6.1B
Total debt$62.7B$41.4B
Net debt / EBITDA4.83.7
Interest cover1.6×5.5×

Dividends and buybacks

PFETMO
Dividends and buybacks
Dividend yield5.9%0.3%
Dividend per share, 12 months$1.72$1.84
Dividend growth a year, past+2.4%over 5 years+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield5.9%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PFE or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Pfizer or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 1.6 times Pfizer ($164B), at today's prices.

How did PFE and TMO stock do over the last 10 years?

Since November 15, 2016, PFE's price moved -5.5% and TMO's +371.0%. With dividends: PFE +49.7% (+4.1% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, PFE or TMO?

The dividend yield at today's price is 5.95% for Pfizer and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid $1.72 and $1.84 per share.

What is the P/E of PFE and TMO?

At today's price, the P/E is 40.7 for PFE and 36.8 for TMO. The median of the last five years was 18.3 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Pfizer or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 6.3% for Pfizer and 14.9% for Thermo Fisher Scientific, and the operating margin – and 17.9%. Revenue was $63.6B and $47.4B.

Which is the better investment, Pfizer or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.